Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections

Almost all patients with autoimmune polyendocrine syndrome type 1 (APS-1) have neutralizing antibodies against type 1 interferons (IFN), important mediators of antiviral defense. Recently, neutralizing anti-IFN antibodies were shown to be a risk factor of severe COVID-19. Here we show in a cohort of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hetemäki, Iivo, Laakso, Saila, Välimaa, Hannamari, Kleino, Iivari, Kekäläinen, Eliisa, Mäkitie, Outi, Arstila, T. Petteri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425955/
https://www.ncbi.nlm.nih.gov/pubmed/34508889
http://dx.doi.org/10.1016/j.clim.2021.108851

Ejemplares similares

Ejemplares similares